MRFF – 2020 Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity

Overview

Applications to this Medical Research Future Fund (MRFF) Coronavirus Research Response: 2020 Respiratory Medicine Clinical Trials Research on COVID-19 grant opportunity must propose a clinical trial that accelerates the implementation of treatments for severe acute respiratory distress in patients infected with COVID-19 in order to support the response to the COVID-19 outbreak in Australia. Applicants should note that the research funded by this grant opportunity is not intended to be used for development of vaccines or anti-viral therapies for COVID-19. These issues are the subject of separate MRFF grant opportunities. The objective of the 2020 Respiratory Medicine Clinical Trials Research on COVID-19 Grant Opportunity is to use clinical trials to accelerate the implementation of treatments for severe acute respiratory distress in patients infected with COVID 19. To be competitive for funding, applicants must propose a clinical trial that delivers against the above objective. The intended outcome of the research funded under this priority is to use clinical trials to accelerate the implementation of safe and effective treatments for severe acute respiratory distress in patients infected with COVID 19. This includes the identification of plausible pathways to clinical practice within 12 months of commencement. Applications must address the desired outcomes described in section 1.3 of the grant guidelines. This opportunity is supported by the Medical Research Future Fund (MRFF).